Warning: The NCBI web site requires JavaScript to function. more...
Current insights in to the pathophysiology of Irritable Bowel Syndrome.
Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG.
Gut Pathog. 2010 May 13;2(1):3.
Related citations
New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.
Crowell MD, Harris L, Jones MP, Chang L.
Curr Gastroenterol Rep. 2005 Aug;7(4):272-9. Review.
Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
Elsenbruch S.
Brain Behav Immun. 2011 Mar;25(3):386-94. Epub 2010 Nov 20. Review.
[The pathophysiology of irritable bowel syndrome].
Zouiten ML, Karoui S, Boubaker J, Fekih M, Mechmeche R, Filali A.
Tunis Med. 2006 May;84(5):269-74. Review. French.
Functional findings in irritable bowel syndrome.
Posserud I, Ersryd A, Simrén M.
World J Gastroenterol. 2006 May 14;12(18):2830-8. Review.
The brain-gut axis in irritable bowel syndrome--clinical aspects.
Mach T.
Med Sci Monit. 2004 Jun;10(6):RA125-31. Epub 2004 Jun 1. Review.
Irritable bowel syndrome, gut microbiota and probiotics.
Lee BJ, Bak YT.
J Neurogastroenterol Motil. 2011 Jul;17(3):252-66. Epub 2011 Jul 13.
Peripheral factors in the pathophysiology of irritable bowel syndrome.
Gunnarsson J, Simrén M.
Dig Liver Dis. 2009 Nov;41(11):788-93. Epub 2009 Aug 8. Review.
Tegaserod for the treatment of irritable bowel syndrome.
Evans BW, Clark WK, Moore DJ, Whorwell PJ.
Cochrane Database Syst Rev. 2004;(1):CD003960. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003960.
New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models.
Barreau F, Ferrier L, Fioramonti J, Bueno L.
Pediatr Res. 2007 Sep;62(3):240-5. Review.
Motility disorders in the irritable bowel syndrome.
Lind CD.
Gastroenterol Clin North Am. 1991 Jun;20(2):279-95. Review.
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.
Irritable bowel syndrome: recent and novel therapeutic approaches.
Andresen V, Camilleri M.
Drugs. 2006;66(8):1073-88. Review.
Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ.
Baillieres Best Pract Res Clin Gastroenterol. 1999 Oct;13(3):461-71. Review.
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
Ohman L, Simrén M.
Dig Liver Dis. 2007 Mar;39(3):201-15. Epub 2007 Jan 30. Review.
New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility.
Gasbarrini A, Lauritano EC, Garcovich M, Sparano L, Gasbarrini G.
Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:111-7. Review.
Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M, Hongo M, Fukudo S.
J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:119-21. doi: 10.1111/j.1440-1746.2011.06640.x.
[Pathophysiology of irritable bowel syndrome].
Torii A.
Nihon Rinsho. 2006 Aug;64(8):1452-5. Review. Japanese.
Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
Scarpignato C, Pelosini I.
Can J Gastroenterol. 1999 Mar;13 Suppl A:50A-65A. Review.
The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM, Denou E, Verdu EF, Bercik P.
Dig Liver Dis. 2009 Dec;41(12):850-3. Epub 2009 Sep 8. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on